DalsnaFinance › IPOs › Syndax Pharmaceuticals Inc › IPO
Syndax Pharmaceuticals Inc completed its initial public offering on NASDAQ on March 3, 2016, pricing at $12.00 a share.
| Ticker | SNDX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | March 3, 2016 |
| Offering price | $12.00 |
| Shares offered | 4,400,000 |
| Total raised | $53M |
Syndax Pharmaceuticals Inc sold 4,400,000 shares at $12.00 each on NASDAQ. Multiplied out, that is $52.8 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $53 million total recorded for the deal.
Syndax Pharmaceuticals Inc — quote, profile and latest news →
Source: SEC EDGAR filings for Syndax Pharmaceuticals Inc. This page is general information, not investment advice.